The Investors forum offers an exciting opportunity for young companies looking for equity capital and/or partnerships. Many promising start-ups applied for this year's forum and following the recent presentation of their test pitches to the jury, 12 selected companies are getting ready to deliver their pitch during the Investors forum breakfast and lunch sessions tomorrow. The winner will also present the winning pitch in the plenary programme at DLSC and will be awarded a partnering ticket with a total value of EUR 2,500 and a half-day PwC Booster Session.
After winning the pitch competition at the DLSC Investors Forum 2023, last year's winner Predica Diagnostics made some great strides on their mission to improve the diagnosis, prognosis and treatment of cervical cancer, announcing their first product earlier this year. Winning the competition was not only great recognition, but also proved helpful to further develop their pitch and to demonstrate the value that Predica may hold for potential investors and partners. Read about how they used the PwC Booster Session in this article: The value of a start-up in pharma, lifesciences and medtech.